Sexual Dysfunction in Young Adult Men

November 9, 2026 updated by: Murat Gulsen, Ondokuz Mayıs University

Prevalence and Associated Factors of Sexual Dysfunction in Sexually Active Men Aged 18 to 40 Years: A Single-Center Cross-Sectional Study

This single-center cross-sectional study aims to determine the prevalence of erectile dysfunction and premature ejaculation in sexually active men aged 18 to 40 years and to evaluate their association with depressive and anxiety symptoms, lifestyle factors, and sociodemographic characteristics. Participants attending outpatient clinics of Ondokuz Mayis University Hospital for routine health check-ups completed a structured questionnaire, the International Index of Erectile Function-15 (IIEF-15), the Premature Ejaculation Diagnostic Tool (PEDT), the Beck Depression Inventory, and the Generalized Anxiety Disorder-7 (GAD-7) scale.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

253

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Samsun, Turkey (Türkiye), 55150
        • Ondokuz Mayis University Faculty of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

Sexually active men aged 18 to 40 years attending outpatient clinics of Ondokuz Mayis University Hospital for routine health check-ups.

Description

Inclusion Criteria:

  • Inclusion Criteria:
  • Male, aged 18 to 40 years
  • Sexual activity within the previous six months
  • Attending Ondokuz Mayis University Hospital outpatient clinics for a routine health check-up
  • Ability to read and write Turkish and to complete the questionnaire
  • Written informed consent

Exclusion Criteria:

  • History of spinal cord injury
  • Active cancer or ongoing chemotherapy/radiotherapy
  • Cognitive, psychiatric, or communication impairment preventing reliable completion of the questionnaire
  • Incomplete or inconsistent questionnaire data precluding analysis

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: OTHER
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort
Sexually active men aged 18-40 years

Men attending outpatient clinics for routine health check-ups who completed IIEF-15, PEDT, Beck Depression Inventory and GAD-7.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of erectile dysfunction
Time Frame: At enrollment (single cross-sectional assessment)

Proportion of participants with an IIEF-15 erectile function domain score of 25 or lower.

At enrollment (single cross-sectional assessment)
Prevalence of premature ejaculation
Time Frame: At enrollment (single cross-sectional assessment)

Proportion of participants with a PEDT total score of 11 or higher.

At enrollment (single cross-sectional assessment)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Association of anxiety symptoms with sexual dysfunction
Time Frame: At enrollment

Association of GAD-7 score (10 or higher defined as anxiety) with erectile dysfunction and premature ejaculation.

At enrollment
Association of depressive symptoms with sexual dysfunction
Time Frame: At enrollment

Association of Beck Depression Inventory score (17 or higher defined as depression) with erectile dysfunction and premature ejaculation.

At enrollment
Association of lifestyle and sociodemographic factors with sexual dysfunction
Time Frame: At enrollment

Association of BMI, waist circumference, smoking, alcohol use, physical activity, working pattern, weekly working hours, education, income and marital status with erectile dysfunction and premature ejaculation.

At enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 7, 2026

Primary Completion (Actual)

July 30, 2026

Study Completion (Actual)

July 30, 2026

Study Registration Dates

First Submitted

November 9, 2026

First Submitted That Met QC Criteria

November 9, 2026

First Posted (Actual)

November 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 16, 2026

Last Update Submitted That Met QC Criteria

November 9, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared publicly as participant consent did not include public data sharing.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe